SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Geronimo — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeronimo
Date of birth1829-06-01
IdentifiersMRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729
Document date1906-10-28
AuthorRoberta Whitehorse-Lindgren, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Sixteen-week review after twelve sessions of therapy. [S]

History of Present Illness

Geronimo returns sixteen weeks after intake, with the interpreter. He finished the twelfth session of cognitive processing therapy last week. Nightmares now come about once every two weeks, and he sleeps six hours most nights. He had one evening of heavy drinking three weeks ago, which he raised himself; since then he has had a single drink on a few evenings. He takes sertraline 50 mg, naltrexone and thiamine without side effects and has not fallen. His stool test was negative and the hepatitis C and B tests show no infection and no immunity to hepatitis B. He says he prays in his own way and that this is part of how he is doing; he did not describe it and was not asked. He wants his zoster and Tdap vaccines today. [S]

ElementDetail
TherapyTwelve of twelve sessions completed
PCL-524, from 56
PHQ-94
AUDIT5, from 19
PEth14 ng/mL
Screening resultsStool test and hepatitis C negative; not infected with or immune to hepatitis B

Review of Systems

SystemResultFinding
PsychiatricPositiveNightmares about once every two weeks; mood steady; no thoughts of suicide
GastrointestinalNegativeNo nausea or abdominal pain
NeurologicalNegativeNo dizziness or falls

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1906-07-08activeS
Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicinesOne tablet dailyOral route1906-07-22activeS
Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium checkOne tablet each morningOral route1906-08-19 to 1906-09-23completedS
Sertraline 50 mg oral tablet, one tablet each morningOne tablet each morningOral route1906-09-23activeS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for fever or aches, no more than 2,000 mg a day while his liver recoversOne or two tablets every 6 hours as needed, no more than 2,000 mg a dayOral route1906-09-02 to 1906-09-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1906-10-28Body height173cmS
1906-10-28Body weight67.6kgS
1906-10-28Body mass index (BMI) [Ratio]22.6kg/m2S
1906-10-28Systolic blood pressure128mm[Hg]S
1906-10-28Diastolic blood pressure76mm[Hg]S
1906-10-28Heart rate70/minS
1906-10-28Respiratory rate16/minS
1906-10-28Body temperature36.5CelS
1906-10-28Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1906-10-28PTSD PCL-5 score [PCL-5]24{score}S
1906-10-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1906-10-28Total score [AUDIT]5{score}S
1906-10-28Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma29U/L10-40 U/LNormalS
1906-10-28Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma25U/L7-56 U/LNormalS
1906-10-28Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma48U/L8-61 U/LNormalS
1906-10-28Phosphatidylethanol [Mass/volume] in Blood14ng/mL<=20 ng/mLNormalS

Physical Exam

Vital signs recorded on 1906-10-28; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/76 seated and 126/74 standing; pulse 70; weight 67.6 kg, BMI 22.6
Mental statusRelaxed and humorous; full range of affect; no thoughts of suicide or of harming anyone
GaitSteady; Timed Up and Go 11 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessedresolvedconfirmed G47.00S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep.
Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not metactiveconfirmed F43.12S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person.
Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinkingactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking.
A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 secondsactiveconfirmed Z91.81S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode.
Acute bronchitis with cough and low fever for six days, chest X-ray clear, oxygen saturation 95%; treated without antibiotics; resolvedresolvedconfirmed J20.9S — Synthetic self-limited illness; not a historical claim and not his documented last illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPTSD symptom severity (PCL-5)Baseline, then every visit during treatmentCompleted today24, from 56
Self-managementTrauma-focused psychotherapy (cognitive processing therapy), sessions attendedWeekly for twelve sessionsCompleted todayTwelve of twelve sessions completed; monthly boosters planned
SurveyDepressive symptoms (PHQ-9)Baseline, then monthly during active treatmentCompleted today4, from 11; item 9 scored 0
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; 988 card carried
Self-managementDrinking since the last visit, against his own goalEvery visitCompleted todayOne heavy evening three weeks ago; otherwise a single drink on a few evenings; AUDIT 5
LaboratoryLiver tests (AST, ALT, GGT) on naltrexoneBefore starting, at four to six weeks, then every three to six monthsCompleted todayAST 29, ALT 25, GGT 48 U/L: normal
LaboratoryPEth, a blood marker of drinking over the past two to four weeksAt baseline and every one to three months during treatment, with consentCompleted today14 ng/mL, from 41
Medication safetyNaltrexone safety: opioid use, nausea, wallet cardEvery visitCompleted todayNo opioid use; no side effects
Medication safetySSRI safety: sodium, bleeding, falls and side effectsSodium within the first month in older adults; review at each dose changeUp to dateSodium 137 mmol/L five weeks ago; no bleeding, dizziness or falls on 50 mg
Medication safetyPrazosin for nightmaresWhen nightmares persist despite first-line treatmentNot indicatedNightmares about once every two weeks; not needed
ExaminationFalls and gait (Timed Up and Go), orthostatic blood pressureAt intake and every visit after a fallCompleted todayTimed Up and Go 11 seconds; no orthostatic drop; no falls
Self-managementTraditional healing alongside clinic care, at his choiceEvery visitCompleted todayHis own prayer and ways continue, as he chooses; nothing asked

Goal progress:

Immunizations given today: Tdap vaccine; no booster he can recall; Recombinant zoster vaccine, first of two doses [S]

Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Adult Immunization Schedule by Age (2026)

Follow-up: Tdap and the first recombinant zoster dose given today; second zoster dose in two to six months. Hepatitis B vaccination offered and to be decided at the next visit. Review in three months with the PCL-5. Booster therapy sessions monthly. Call the clinic or 988 at any hour. [S]